Theralizumab | 906068-56-2 - MedChemExpress
2023-02-23 09:32 作者:bili_92778524386 | 我要投稿
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
Theralizumab
品牌:MedChemExpress (MCE)
Drug_Names:Theralizumab
CAS:906068-56-2
产品活性:Theralizumab (TGN1412) 是一种超级激动剂抗 CD28 单克隆抗体,可直接刺激 T 细胞。Theralizumab 可用于类风湿性关节炎的研究[1][2]。
存储条件:Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性: Theralizumab (TGN1412) 是一种超激动剂抗CD28 单克隆抗体,可直接刺激 T 细胞。 Theralizumab可用于类风湿性关节炎的研究[1][2]。
参考文献:
Thomas Hünig. The rise and fall of the CD28 superagonist TGN1412 and its return as TAB08: a personal account. FEBS J. 2016 Sep;283(18):3325-34.
Dmitry Tyrsin, et al. From TGN1412 to TAB08: the return of CD28 superagonist therapy to clinical development for the treatment of rheumatoid arthritis. Clin Exp Rheumatol. Jul-Aug 2016;34(4 Suppl 98):45-8.